Navigation Links
Economic factors may affect getting guideline-recommended breast cancer treatment
Date:12/8/2013

ATLANTA Women with interruptions in health insurance coverage or with low income levels had a significantly increased likelihood of failing to receive breast cancer care that is in concordance with recommended treatment guidelines, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Dec. 6-9.

Women with a break in their insurance coverage had a 3.5-fold higher likelihood of nonconcordance with National Comprehensive Cancer Network (NCCN) guidelines for radiation therapy and chemotherapy compared with women with uninterrupted coverage.

"We found that women who had no insurance at some point during treatment, women with lower incomes compared with those in the highest income categories, and women who held more debt at the time of diagnosis were less likely to receive all of the recommended breast cancer treatments," said Jean A. McDougall, Ph.D., M.P.H., a postdoctoral fellow at the Fred Hutchinson Cancer Research Center in Seattle, Wash. "Documenting and understanding these disparities is important for connecting women who are at high risk for not receiving all of their treatment with a patient navigator or social worker ahead of time so that we might increase the likelihood that they will get recommended treatment."

McDougall and colleagues conducted a population-based cohort study of 1,344 women from the Seattle-Puget Sound area diagnosed with breast cancer between 2004 and 2011. Using data from the cancer registry records, pathology reports, and patient self-reports, the researchers assessed whether or not the treatment received was in concordance with guidelines issued by the NCCN.

The researchers found that women with an annual family income of less than $50,000 were more than twice as likely to have received care that was not in concordance with guidelines for radiation therapy compared with women with an income of greater than $90,000 per year. In addition, they had an almost five times higher likelihood for nonconcordance with chemotherapy guidelines, and an almost four times higher likelihood for nonconcordance with endocrine therapy guidelines.

They also found that women who had consistent financial insecurity or who had debt at the time of cancer diagnosis had an increased likelihood for nonconcordance with American Society of Clinical Oncology/NCCN Quality Measures.

In addition, women who had problems talking to a doctor, women who did not have anyone to accompany them for their hospital visits, and women who did not have anyone to take care of them and their household chores, were less likely to receive NCCN guideline-recommended chemotherapy.

"Surprisingly, we found that education or the facility where a woman was treated was not associated with receipt of guideline-recommended care," McDougall said. "Our results suggest that further studies are needed to address the root cause of these inequities, and to develop effective interventions."


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Mount Sinai Receives $5 Million in Funding from the NYC Economic Development Corporation to Establish New Institute of Technology
2. Education -- not fertility -- key for economic development
3. Cayman’s Special Economic Zone signs up new channel partner in Western Canada
4. Business Forecaster and Global Futurist Jack Uldrich to Keynote Economic Development Summit
5. Registration for November 7th Center for Hispanic Leadership Hispanic Workforce and Economic Development Summit ClosesTonight
6. IQWiG: First health economic evaluation completed
7. New report: Companies created from federally funded university research fuel american innovation, economic growth
8. Fifth Third Bank to Sponsor the Ohio Hispanic Workforce & Economic Development Summit on November 7th
9. Center for Hispanic Leadership Ohio to Hold Inaugural Hispanic Workforce and Economic Development Summit OCHLA Aims to Boost Hispanic Entrepreneurs
10. Immigration bill offers big economic boost but no major health benefits
11. FHLBank Topeka Awards Economic Development Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2020)... ... May 26, 2020 , ... ... two leading RevSpring solutions—Talksoft® patient messaging and IVR Advantage™--for Loyale customers. Talksoft ... through automated and precise texts, IVR reminders and email messages tailored to ...
(Date:5/25/2020)... ... May 23, 2020 , ... Winemaker Grant Long Jr. is introducing ... present something whimsical and delicious in these complicated times,” he said, in announcing the ... 2018 Grenache ($24.99). The Chardonnay and Red Wine Blend are sourced in the Napa ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... leader in cancer biomarker assays, announced today that Cigna has added ROMA® (Risk ... a global health service company dedicated to improving the health, well-being, and peace ...
(Date:5/21/2020)... ... 21, 2020 , ... In response to Michigan Governor Gretchen ... 28th and all businesses will be required to have covid-19 employee screening, AmeriCare ... As an essential business, AmeriCare Medical began this precautionary process in early March, ...
(Date:5/21/2020)... ... May 21, 2020 , ... A new report ... Group, details over 90 companies involved in the point of care test industry. ... for preliminary testing, COVID-19 has made point-of-care more important than in the past, according ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... ... , ... Labyrinthe Labs has announced the launch of its brand new and ... designed for fast-action relief of joint and muscle soreness, Lefa is botanically powered by ... joints and muscles. , According to the National Institutes of Health , ...
(Date:5/16/2020)... ... , ... The private clinic, CLNQ has launched a coronavirus antibody test ... which is manufactured by Abbott has been CE certified and previously had FDA approval. ... finger-prick blood testing kit to be sent their home. The sample is then ...
(Date:5/15/2020)... ... May 15, 2020 , ... AppleGate Recovery, ... Recovery Centers (MARC), an office-based opioid treatment (OBOT) program with two locations near ... (MAT) and recovery services in a physician’s office setting. , AppleGate Recovery ...
Breaking Medicine Technology: